Effect of Pyran on Latency After Herpes Simplex Virus Infections

The immunomodulator pyran protected mice against both herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections. In infections of the lip with HSV-1, prophylactic administration of pyran reduced the severity of the herpetic lesions and enhanced their resolution, but did not decrease the high...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Morahan, Page S., Cline, Paul F., Breinig, Mary C., Murray, Byron K.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 1979
主題:	Pharmacology and Therapeutics
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352709/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/464586/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.15.4.547
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!